Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the <i>SFN</i> gene in advanced stage, high‐risk, neuroblastic tumor patients
Barbara Banelli(Ospedale Policlinico San Martino), Massimo Romani(Ospedale Policlinico San Martino), Katia Mazzocco(Istituto Giannina Gaslini), Claudio Brigati(Alleanza Contro il Cancro), Gian Paolo Tonini(Città della Speranza Foundation), Ida Casciano(Alleanza Contro il Cancro), Giorgio Allemanni(Alleanza Contro il Cancro), Paola Scaruffi(Azienda Ospedaliera S.Maria), Luana Borzì(Alleanza Contro il Cancro), Angela Di Vinci(Alleanza Contro il Cancro), Stefano Bonassi(San Raffaele University of Rome)
Cited by 28
Related Papers
HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2002|1.4k
An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans
|Carcinogenesis|2006|1k
Buccal micronucleus cytome assay
|Nature Protocols|2009|635
The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: The HUMN project perspective on current status and knowledge gaps
|Mutation Research/Reviews in Mutation Research|2008|596